Search results
Gregory Raskin is the Senior Vice President of Technology Development at Memorial Sloan Kettering. He leads a team of professionals who work within the Office of Technology Development’s (OTD) three units: Technology Management and Commercialization, Contracts, and Operations and Finance.
Sep 29, 2018 · The vice president, Dr. Gregory Raskin, oversees hospital ventures with for-profit companies. As compensation for representing the hospital on the biotech company’s board, Raskin received stock...
Sep 29, 2018 · The vice president, Dr. Gregory Raskin, oversees hospital ventures with for-profit companies. As compensation for representing the hospital on the biotech company’s board, Dr. Raskin received...
Sep 20, 2018 · “This is an incredibly expensive undertaking — it needs a lot of money,” Dr. Gregory Raskin, the hospital’s vice president of technology development, said in an interview.
Sep 29, 2018 · The vice president, Dr. Gregory Raskin, oversees hospital ventures with for-profit companies. As compensation for representing the Manhattan-based hospital on the biotech company’s board,...
Oct 2, 2018 · The Memorial Sloan Kettering (MSK) Cancer Center in Manhattan, New York, also announced that its vice president Gregory Raskin, a physician, will turn over to his employer nearly $1.4m (£1.1m; €1.2m) of a windfall stake in a biotech company called Y-mAbs Therapeutics, which specialises in children’s cancer treatments derived from research ...
Gregory Raskin is the Senior Vice President of Technology Development at Memorial Sloan Kettering. He leads a team of professionals who work within the Office of Technology Development’s (OTD) three units: Technology Management and Commercialization, Contracts, and Operations and Finance.
